Search

You searched for "Ophthalmology"

3284 results found

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)

3 February 2023 | | EYE - General
Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...

Understanding amniotic membrane grafts

1 June 2019 | | EYE - Cornea, EYE - General
Safa Elhassan gives a brief review of amniotic membrane grafts and their application in theatre and clinic-based settings. Amniotic membrane (AM) transplant has been an established adjuvant treatment for many corneal, conjunctival and scleral disorders in ophthalmic clinical practice with...

The TOPCON / OIA Imaging Competition and a brief history of ophthalmic photography

3 June 2021 | | EYE - Imaging, EYE - General
We hope you like and appreciate the image forming the cover of the June/July 2021 edition of Eye News. The Ophthalmic Imaging Association (OIA) was honoured to have been invited to submit a series of images from the winners of...

Traumatic ‘toy’ gun injury leading to permanent vision loss

6 April 2021 |
Pseudoxanthoma elasticum (PXE) is a progressive, inherited disorder of connective tissue that affects the skin, cardiovascular system and retina. Ocular manifestations of the disease are related to Bruch’s membrane, a thin elastic tissue layer located between the retinal pigment epithelium...

Macular imagery: observing the visual sensations pre- and post-Jetrea injections

25 September 2021 | | EYE - Vitreo-Retinal, EYE - General
A 63-year-old woman, a professional painter, was diagnosed with vitreomacular traction (VMT) in 2017. She had a history of metamorphopsia, drop in visual acuity (VA) in the left eye (6/6 in the RE; 6/18 in the LE), foveal vitreomacular traction...

Avoiding investigations through history taking and examinations to differentiate serious from comparably benign aetiology

1 December 2022 | | EYE - General
*Joint first authors. Introduction Anisocoria can be a sign of neurological deficit, necessitating numerous investigations [1]. This case report explores how expensive and time-consuming investigations can be avoided by thorough history taking and examination to differentiate serious from comparably benign...

Burning vision: vision loss from misuse of ‘toy’ laser pens in children

1 April 2014 | | EYE - Cornea
A case series of five children with macular burns due to the misuse of novelty laser products, purchased online or abroad, was undertaken at the Royal Hallamshire Hospital and The Children’s Hospital, Sheffield [1]. All patients were from the Sheffield...

Collaborating across the Caribbean to tackle diabetic retinopathy

1 December 2017 | | EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme has been running since 2004, with a focus on improving the quality and quantity of eye care training in low-income countries [1]. In 2014, the Diabetic Retinopathy Network (DR-NET) was established [2]. This is a...

Burnout: ubiquitous and unavoidable?

3 August 2023 | | EYE - General
Meriam Islam reminds us of the importance of ‘putting our oxygen mask on first’ and avoiding burnout while we progress through our careers. Burnout. It’s a term we hear a lot. What does it mean though? According to Merriam Webster,...

Two cases of acute syphilitic posterior placoid chorioretinitis

4 December 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Syphilis has re-emerged as a significant public health concern, with the World Health Organization (WHO) estimating that 8 million adults aged 15–49 acquired syphilis in 2022. Untreated syphilis can have severe consequences, including cardiovascular, neurological and ocular complications. Ocular manifestations...

Javier Bardem 'donates' his iris to the Eyes of the World Foundation to fight avoidable blindness

21 September 2022
The Eyes of the World Foundation has launched 'Iris of the World' to raise awareness of the deficiencies in eye care in the most vulnerable areas of the world, and to defend the universal right to vision.

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...